- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03824717
MEV 90 of 0.5% Ropivacaine In Infraclavicular Blocks (MEV90ROPI)
Minimum Effective Volume of 0.5% Ropivacaine for Ultrasound-Guided Infraclavicular Block
Nerve blocks are routinely performed perioperatively to provide anesthesia and analgesia for various surgical procedures on the upper limb. These blocks are performed with the aid of an ultrasound machine to improve the success rate. Below the clavicle approach to these nerves is used for surgeries below the elbow, forearm and hand efficiently.
Ultrasound guidance for such blocks allows direct visualisation of the needle and the spread of the freezing medication (local anesthetic) in real-time therefore reducing complications and improving success rates of blocks. It may be possible that a smaller volume of local anesthetic in this setting may allow effective anesthesia while lowering the adverse effects. The aim of this study is to find out the lowest volume of the local anesthetic that will be effective in blocking the nerves adequately.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
This is a dose finding study. Volume assignment of ropivacaine will be carried out using a Biased Coin Design up and down method. In this method, the volume of local anesthetic (ropivacaine) administered to each patient will depends on the response of the previous patient. In the event of block failure, the next subject will receive an additional 2 mL of volume compared with the previous patient. In the event of block success, the next patient will receive either the same volume as the last patient or a 2 mL reduction in volume (per the biased coin design with a probability of the same volume being 0.9 and lower volume being 0.1). The first patient in the study will receive 30 mL and depending on the block success, the volume of the next block will be increased or decreased. The biased coin design is well described and established in other minimum volume studies.
All patients will have the block in the block room with standard monitoring (non-invasive blood pressure, pulse-oximetry, electrocardiogram) and mild sedation with midazolam and fentanyl. All blocks will be performed by staff anesthesiologists with a subspecialty in regional anesthesia and who work routinely in the block room or by a resident or fellow who is directly supervised by one of these staff anesthesiologist.
There will be two follow up telephone call to all patients enrolled in this study 24 hours post block insertion and one at 7 days to discuss length of block duration, any postoperative nausea/vomiting, any ongoing numbness or tingling, and overall satisfaction with the block. The participants will be informed of this phone call as part of the consent process and their telephone number will be confirmed.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Shalini Dhir, MD, FRCPC
- Phone Number: 64219 +1 519 646 6000
- Email: shalini.dhir@sjhc.london.on.ca
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Adults aged 18 to 80 years
- Amercian Society of Anesthesia physical status I, II, III
- Patients undergoing upper limb surgeries (with/without sedation)
- Ability to provide written informed consent
Exclusion Criteria:
- Patient refusal
- Known history of sensitivity or contraindications to study drugs
- Pregnant patients
- Infection at the site of administration of block
- Significant blood coagulation disorders
- Neurological deficits involving brachial plexus
- Patients on any medication which is known to have drug interactions with the study drugs
- Patients who receive general anesthesia/ narcotic supplements
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Other: Ropivacaine dosage
Dose finding study - The volume of 0.5% ropivacaine used to achieve surgical anesthesia in infraclavicular brachial plexus block
|
Biased coin design up and down dose finding study of 0.5% ropivacaine to achieve a successful infraclavicular brachial plexus block
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
ED90 of 0.5% Ropivacaine
Time Frame: 30 minutes
|
Volume used to achieve sensory and motor blockade (surgical anesthesia)
|
30 minutes
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Surgical anesthesia
Time Frame: 30 minutes
|
Sensory and motor blockade tested using pin prick sensation ( 0 - normal sensation and can feel pin-prick, 1 - touch only, 2 - no sensation of touch or pinprick) and motor function of the ulnar, radial and median nerves.
|
30 minutes
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Duration of sensory anesthesia
Time Frame: 8 to 10 hours
|
Duration of analgesia - time from administration of block to Visual analogue scale score more than 4 or patient request for first analgesic dose
|
8 to 10 hours
|
Complications during block placement
Time Frame: 30 minutes
|
Incidence of paresthesia during needle insertion, vascular or pleural puncture
|
30 minutes
|
Postoperative complications 24 hours and 7 days
Time Frame: 24 hours and 7 days
|
Presence or absence of tingling, numbness, weakness of limb will be noted.
Patient satisfaction as satisfied or unsatisfied will be noted.
|
24 hours and 7 days
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Anticipated)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 112062
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Infraclavicular Brachial Plexus Block
-
University of MalayaCompletedBrachial Plexus Block | Infraclavicular | Ultrasound Guided
-
Diskapi Yildirim Beyazit Education and Research...CompletedBrachial Plexus BlockTurkey
-
University of MalayaCompletedBrachial Plexus Block
-
B.P. Koirala Institute of Health SciencesCompleted
-
University Hospital, AntwerpCompletedSurgery | Anesthesia | Brachial Plexus Block | Nerve BlockBelgium
-
JongHae KimCompletedInterscalene Brachial Plexus BlockKorea, Republic of
-
Minia UniversityCompletedSupraclavicular Brachial Plexus BlockEgypt
-
Federal University of São PauloCompletedAxillary Brachial Plexus BlockBrazil
-
Sohag UniversityNot yet recruitingBrachial Plexus Block
-
Sohag UniversityCompleted
Clinical Trials on Dose of ropivacaine
-
Benaroya Research InstituteRecruitingPost Operative PainUnited States
-
Hopital de l'Enfant-JesusSanofiCompleted
-
Sunnybrook Health Sciences CentreThe Physicians' Services Incorporated FoundationUnknown
-
Hospices Civils de LyonCompleted
-
Cui XuleiCompletedAnalgesia | Hepatectomy | Nerve BlockChina
-
Northwestern UniversityCompletedPostoperative PainUnited States
-
Ziekenhuis Oost-LimburgNot yet recruitingAnesthesia | Hallux Valgus
-
Baylor College of MedicineWithdrawn
-
University of California, DavisRecruitingPain, Postoperative | Transplant;Failure,KidneyUnited States
-
China Medical University, ChinaCompleted